{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T05:06:40Z","timestamp":1787720800660,"version":"build-2784847793"},"reference-count":49,"publisher":"Portland Press Ltd.","issue":"1","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,2,1]]},"abstract":"<jats:p>HGPS (Hutchinson\u2013Gilford progeria syndrome) is a rare genetic disease affecting children causing them to age and die prematurely. The disease is typically due to a point mutation in the coding sequence for the nuclear intermediate-type filament protein lamin A and gives rise to a dominant-negative splice variant named progerin. Accumulation of progerin within nuclei causes disruption to nuclear structure, causes and premature replicative senescence and increases apoptosis. Now it appears that accumulation of progerin may have more widespread effects than previously thought since the demonstration that the presence and distribution of some nucleolar proteins are also adversely affected in progeria cells. One of the major breakthroughs both in the lamin field and for this syndrome is that many of the cellular defects observed in HGPS patient cells and model systems can be restored after treatment with a class of compounds known as FTIs (farnesyltransferase inhibitors). Indeed, it is demonstrated that FTI-277 is able to completely restore nucleolar antigen localization in treated progeria cells. This is encouraging news for the HGPS patients who are currently undergoing clinical trials with FTI treatment.<\/jats:p>","DOI":"10.1042\/bst0380287","type":"journal-article","created":{"date-parts":[[2010,1,20]],"date-time":"2010-01-20T16:17:54Z","timestamp":1264004274000},"page":"287-291","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Progeria, the nucleolus and farnesyltransferase inhibitors"],"prefix":"10.1042","volume":"38","author":[{"given":"Ishita\u00a0S.","family":"Mehta","sequence":"first","affiliation":[{"name":"Laboratory of Nuclear and Genomic Health, Centre for Cell and Chromosome Biology, Division of Biosciences, School of Health Sciences and Social Care, Brunel University, Uxbridge UB8 3PH, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna\u00a0M.","family":"Bridger","sequence":"additional","affiliation":[{"name":"Laboratory of Nuclear and Genomic Health, Centre for Cell and Chromosome Biology, Division of Biosciences, School of Health Sciences and Social Care, Brunel University, Uxbridge UB8 3PH, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian\u00a0R.","family":"Kill","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular Gerontology, Centre for Cell and Chromosome Biology, Division of Biosciences, School of Health Sciences and Social Care, Brunel University, Uxbridge UB8 3PH, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2010,1,19]]},"reference":[{"key":"2021111720281650400_B1","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1172\/JCI37679","article-title":"Laminopathies and the long strange trip from basic cell biology to therapy","volume":"119","author":"Worman","year":"2009","journal-title":"J. Clin. Invest."},{"key":"2021111720281650400_B2","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1126\/science.1084125","article-title":"Lamin a truncation in Hutchinson\u2013Gilford progeria","volume":"300","author":"De\u00a0Sandre-Giovannoli","year":"2003","journal-title":"Science"},{"key":"2021111720281650400_B3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature01629","article-title":"Recurrent de novo point mutations in lamin A cause Hutchinson\u2013Gilford progeria syndrome","volume":"423","author":"Eriksson","year":"2003","journal-title":"Nature"},{"key":"2021111720281650400_B4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1101\/gad.1652708","article-title":"Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin","volume":"22","author":"Dechat","year":"2008","journal-title":"Genes Dev."},{"key":"2021111720281650400_B5","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1093\/hmg\/ddp184","article-title":"Activating the synthesis of progerin, the mutant prelamin A in Hutchinson\u2013Gilford progeria syndrome, with antisense oligonucleotides","volume":"18","author":"Fong","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"2021111720281650400_B6","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1101\/gad.1735208","article-title":"The A- and B-type nuclear lamin networks: microdomains involved in chromatin organization and transcription","volume":"22","author":"Shimi","year":"2008","journal-title":"Genes Dev."},{"key":"2021111720281650400_B7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1474-9726.2007.00270.x","article-title":"Primary laminopathy fibroblasts display altered genome organization and apoptosis","volume":"6","author":"Meaburn","year":"2007","journal-title":"Aging Cell"},{"key":"2021111720281650400_B8","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1083\/jcb.110.5.1489","article-title":"Isoprenylation is required for the processing of the lamin A precursor","volume":"110","author":"Beck","year":"1990","journal-title":"J. Cell Biol."},{"key":"2021111720281650400_B9","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1242\/jcs.107.4.1019","article-title":"The role of isoprenylation in membrane attachment of nuclear lamins. A single point mutation prevents proteolytic cleavage of the lamin A precursor and confers membrane binding properties","volume":"107","author":"Hennekes","year":"1994","journal-title":"J. Cell Sci."},{"key":"2021111720281650400_B10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/ng871","article-title":"Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice","volume":"31","author":"Pendas","year":"2002","journal-title":"Nat. Genet."},{"key":"2021111720281650400_B11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1152\/physrev.00047.2005","article-title":"Nuclear lamins: laminopathies and their role in premature ageing","volume":"86","author":"Broers","year":"2006","journal-title":"Physiol. Rev."},{"key":"2021111720281650400_B12","doi-asserted-by":"crossref","first-page":"12879","DOI":"10.1073\/pnas.0506001102","article-title":"Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson\u2013Gilford progeria syndrome","volume":"102","author":"Capell","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111720281650400_B13","doi-asserted-by":"crossref","first-page":"39741","DOI":"10.1074\/jbc.R600033200","article-title":"Prelamin A farnesylation and progeroid syndromes","volume":"281","author":"Young","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2021111720281650400_B14","doi-asserted-by":"crossref","first-page":"8963","DOI":"10.1073\/pnas.0402943101","article-title":"Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson\u2013Gilford progeria syndrome","volume":"101","author":"Goldman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111720281650400_B15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nm1204","article-title":"Reversal of the cellular phenotype in the premature aging disease Hutchinson\u2013Gilford progeria syndrome","volume":"11","author":"Scaffidi","year":"2005","journal-title":"Nat. Med."},{"key":"2021111720281650400_B16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0921-4410(04)22006-3","article-title":"Farnesyltransferase inhibitors","volume":"22","author":"Adjei","year":"2005","journal-title":"Cancer Chemother. Biol. Response Modif."},{"key":"2021111720281650400_B17","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1093\/hmg\/ddi326","article-title":"Incomplete processing of mutant lamin A in Hutchinson\u2013Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition","volume":"14","author":"Glynn","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"2021111720281650400_B18","doi-asserted-by":"crossref","first-page":"14416","DOI":"10.1073\/pnas.0503712102","article-title":"Inhibiting farnesylation reverses the nuclear morphology defect in a HeLa cell model for Hutchinson\u2013Gilford progeria syndrome","volume":"102","author":"Mallampalli","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111720281650400_B19","doi-asserted-by":"crossref","first-page":"12873","DOI":"10.1073\/pnas.0505767102","article-title":"Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes","volume":"102","author":"Toth","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111720281650400_B20","doi-asserted-by":"crossref","first-page":"10291","DOI":"10.1073\/pnas.0504641102","article-title":"Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson\u2013Gilford progeria syndrome mutation","volume":"102","author":"Yang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111720281650400_B21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1474-9726.2008.00382.x","article-title":"Increased mechanosensitivity and nuclear stiffness in Hutchinson\u2013Gilford progeria cells: effects of farnesyltransferase inhibitors","volume":"7","author":"Verstraeten","year":"2008","journal-title":"Aging Cell"},{"key":"2021111720281650400_B22","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1242\/jcs.03263","article-title":"DNA damage responses in progeroid syndromes arise from defective maturation of prelamin A","volume":"119","author":"Liu","year":"2006","journal-title":"J. Cell Sci."},{"key":"2021111720281650400_B23","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.1124875","article-title":"A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria","volume":"311","author":"Fong","year":"2006","journal-title":"Science"},{"key":"2021111720281650400_B24","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1172\/JCI28968","article-title":"A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson\u2013Gilford progeria syndrome mutation","volume":"116","author":"Yang","year":"2006","journal-title":"J. Clin. Invest."},{"key":"2021111720281650400_B25","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1074\/jbc.M708138200","article-title":"Eliminating the synthesis of mature lamin A reduces disease phenotypes in mice carrying a Hutchinson\u2013Gilford progeria syndrome allele","volume":"283","author":"Yang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"2021111720281650400_B26","doi-asserted-by":"crossref","first-page":"15902","DOI":"10.1073\/pnas.0807840105","article-title":"A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model","volume":"105","author":"Capell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111720281650400_B27","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1542\/peds.2007-1356","article-title":"New approaches to progeria","volume":"120","author":"Kieran","year":"2007","journal-title":"Pediatrics"},{"key":"2021111720281650400_B28","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/gerona\/63.8.777","article-title":"Highlights of the 2007 Progeria Research Foundation scientific workshop: progress in translational science","volume":"63","author":"Gordon","year":"2008","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"2021111720281650400_B29","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1083\/jcb.119.4.725","article-title":"Pathway of incorporation of microinjected lamin A into the nuclear envelope","volume":"119","author":"Goldman","year":"1992","journal-title":"J. Cell Biol."},{"key":"2021111720281650400_B30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/excr.2002.5605","article-title":"Unraveling the organization of the internal nuclear matrix: RNA-dependent anchoring of NuMA to a lamin scaffold","volume":"279","author":"Barboro","year":"2002","journal-title":"Exp. Cell Res."},{"key":"2021111720281650400_B31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1242\/jcs.108.2.635","article-title":"Lamin proteins form an internal nucleoskeleton as well as a peripheral lamina in human cells","volume":"108","author":"Hozak","year":"1995","journal-title":"J. Cell Sci."},{"key":"2021111720281650400_B32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1242\/jcs.104.2.297","article-title":"Internal lamin structures within G1 nuclei of human dermal fibroblasts","volume":"104","author":"Bridger","year":"1993","journal-title":"J. Cell. Sci."},{"key":"2021111720281650400_B33","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1101\/gad.842600","article-title":"Nuclear organization of DNA replication in primary mammalian cells","volume":"14","author":"Kennedy","year":"2000","journal-title":"Genes Dev."},{"key":"2021111720281650400_B34","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1083\/jcb.125.6.1201","article-title":"Dynamic properties of nuclear lamins: lamin B is associated with sites of DNA replication","volume":"125","author":"Moir","year":"1994","journal-title":"J. Cell Biol."},{"key":"2021111720281650400_B35","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1242\/jcs.112.24.4651","article-title":"Colocalization of intranuclear lamin foci with RNA splicing factors","volume":"112","author":"Jagatheesan","year":"1999","journal-title":"J. Cell Sci."},{"key":"2021111720281650400_B36","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1242\/jcs.046284","article-title":"Lamin B1 maintains the functional plasticity of nucleoli","volume":"122","author":"Martin","year":"2009","journal-title":"J. Cell Sci."},{"key":"2021111720281650400_B37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1242\/jcs.67.1.217","article-title":"Nucleolar nomenclature","volume":"67","author":"Jordan","year":"1984","journal-title":"J. Cell Sci."},{"key":"2021111720281650400_B38","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1242\/jcs.99.3.465","article-title":"The nucleolus today","volume":"99","author":"Hernandez-Verdun","year":"1991","journal-title":"J. Cell Sci."},{"key":"2021111720281650400_B39","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1242\/jcs.95.3.371","article-title":"A 116,000 Mr nucleolar antigen specific for the dense fibrillar component of the nucleoli","volume":"95","author":"Masson","year":"1990","journal-title":"J. Cell Sci."},{"key":"2021111720281650400_B40","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1242\/jcs.109.6.1253","article-title":"Localisation of the Ki-67 antigen within the nucleolus: evidence for a fibrillarin-deficient region of the dense fibrillar component","volume":"109","author":"Kill","year":"1996","journal-title":"J. Cell Sci."},{"key":"2021111720281650400_B41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00292451","article-title":"Silver staining, immunofluorescence, and immunoelectron microscopic localization of nucleolar phosphoproteins B23 and C23","volume":"90","author":"Spector","year":"1984","journal-title":"Chromosoma"},{"key":"2021111720281650400_B42","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/j.1460-2075.1987.tb02447.x","article-title":"A constitutive nucleolar protein identified as a member of the nucleoplasmin family","volume":"6","author":"Schmidt-Zachmann","year":"1987","journal-title":"EMBO J."},{"key":"2021111720281650400_B43","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF00286991","article-title":"Scl 70 autoantibodies from scleroderma patients recognize a 95\u00a0kDa protein identified as DNA topoisomerase I","volume":"94","author":"Guldner","year":"1986","journal-title":"Chromosoma"},{"key":"2021111720281650400_B44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1172\/JCI112809","article-title":"Autoantibody to RNA polymerase I in scleroderma sera","volume":"79","author":"Reimer","year":"1987","journal-title":"J. Clin. Invest."},{"key":"2021111720281650400_B45","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nrm2184","article-title":"The multifunctional nucleolus","volume":"8","author":"Boisvert","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2021111720281650400_B46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tcb.2006.11.010","article-title":"Nucleolin: a multiFACeTed protein","volume":"17","author":"Mongelard","year":"2007","journal-title":"Trends Cell Biol."},{"key":"2021111720281650400_B47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1768-322X.1985.tb00387.x","article-title":"Fibrillarin: a new protein of the nucleolus identified by autoimmune sera","volume":"54","author":"Ochs","year":"1985","journal-title":"Biol. Cell"},{"key":"2021111720281650400_B48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1242\/jcs.111.3.359","article-title":"Effects of anti-fibrillarin antibodies on building of functional nucleoli at the end of mitosis","volume":"111","author":"Fomproix","year":"1998","journal-title":"J. Cell Sci."},{"key":"2021111720281650400_B49","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.exger.2004.02.002","article-title":"Aging of Hutchinson\u2013Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis","volume":"39","author":"Bridger","year":"2004","journal-title":"Exp. Gerontol."}],"container-title":["Biochemical Society Transactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/38\/1\/287\/547629\/bst0380287.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/38\/1\/287\/547629\/bst0380287.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T00:29:00Z","timestamp":1637195340000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article\/38\/1\/287\/66264\/Progeria-the-nucleolus-and-farnesyltransferase"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,19]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1,19]]},"published-print":{"date-parts":[[2010,2,1]]}},"URL":"https:\/\/doi.org\/10.1042\/bst0380287","relation":{},"ISSN":["0300-5127","1470-8752"],"issn-type":[{"value":"0300-5127","type":"print"},{"value":"1470-8752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,19]]}}}